Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foster NEXThaler vs Foster pMDI in Controlled Asthma
NCT03453112Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Oct 2017
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone dipropionate, formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Oct 2017; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03453112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03453112.